期刊文献+

临床药师会诊评价与典型病例分析 被引量:1

Evaluation of Clinical Pharmacist Consultations and Typical Case Analysis
下载PDF
导出
摘要 目的回顾分析临床药师会诊病例,评价会诊效果。方法对2011年1月—2014年12月临床药师参与731例次会诊进行系统回顾,统计申请科室、会诊问题分类、感染涉及器官系统、会诊目的、感染问题会诊建议分类、建议采纳情况、感染问题会诊效果,对典型病例进行分析。结果会诊数量及覆盖科室数逐年增加;会诊目的以制定抗感染治疗方案、确定抗感染疗程、确定抗菌药物剂量为主;会诊感染问题占86.0%,建议采纳率83.6%,建议采纳后临床有效率为84.3%;会诊非感染问题占14.0%,建议采纳率为100.0%。结论临床药师的专业技能得到医生认可;抗感染问题是深入开展临床药学工作的切入点。 Objective To evaluate the effect of clinical pharmacists on cases consultation by retrospective analysis.Methods Seven hundred and thirty-one consultation cases from January 2011 to December 2014 were systematically reviewed, and the clinical department, question classification, organ system of infection, consultation purpose, recommendation variety to infection problems, acception percentage, infection problem outcome were recorded.Furthermore, the typical cases were analysed.Results The number of consultations and clinical departments increased by years, formulating anti-infective therapeutic regimen, determining duration of therapy and drug dosage were the main purposes of consultation.The proportion of infection problems was 86.0%, adoption rate of recommendations was 83.6%, the clinical efficacy rate was 84.3% among them.The proportion of non-infectious problems was 14.0%, adoption rate of recommendations was 100.0%.Conclusion Clinical pharmacists' professional skills are respected by doctors.Anti-infection problem is a breakthrough point for deeply developing the work of clinical pharmacists.
出处 《医药导报》 CAS 2017年第5期569-572,共4页 Herald of Medicine
基金 东莞市科技计划项目(201210515000425)
关键词 临床药师 临床药学 抗感染 合理用药 Clinical pharmacist Clinical pharmacy Anti-infection Rational drug use
  • 相关文献

参考文献3

二级参考文献24

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:238
  • 2EMEA. Note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections[ EB/OL]. http://www. emea. europa. eu/pdfs/human/ewp/055895en: pdf. ,2004 - 04 - 22.
  • 3中华人民共和国卫生部药政局.抗菌药物临床研究指导原则.新药(西药)临床研究指导原则汇编.1993年7月.
  • 4FDA. Guidance For Industry. Developing antimicrobial drugs - general considerations for clinical, trial [EB/OL]. http://www.fda. gov, 1998-07.
  • 5FDA. Guidance For Industry. Evaluating clinical studies of antimicrobials in the division of anti - infective drugs products [EB/OL]. http://www. fda. gov,1997 -02 - 18.
  • 6MHLW.抗菌藥臨床評価のガイドライン[EB/OL].http://www.mhlw.go.jp,1998-08-25.
  • 7NAOTOSHI Y, KAORU I, HIDEO N, et al. Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats [ J ]. Drug Metab Dispos, 1999,27 ( 6 ) :724-730.
  • 8HAROUTIUNIAN S, RAT Z Y, RABINOVICH B, et al. Valproic acid plasma concentration decreases in a dose- independent manner following administration of meropenem : a retrospective study [ J ]. J Clin Pharmacol, 2009,49 ( 11 ) : 1363 - 1369.
  • 9LEE S G, KIM J H, JO0 J Y, et al. Seven cases of dec- reased serum valproic acid concentration during concomitant use of carbapenem antibiotics [ J ]. Korean J Lab Med, 2007, 27(5) :338-343.
  • 10LUNDE J L, NELSON R E, STORANDT H F. Acute seiz- ures in a patient receiving divalproex sodium after starting ertapenem therapy [ J ]. Pharmacotherapy, 2007,27 ( 8 ) : 1202-1205.

共引文献889

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部